COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM

COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM operates as a nonprofit clinical research and patient care organization focused on delivering community-based oncology services. Its core capabilities center on the administration of clinical trials, chemotherapy administration, supportive care coordination, and translational research implementation within oncology settings. The organization specializes in integrating evidence-based protocols into outpatient oncology practice, ensuring adherence to NCCN guidelines and federal regulatory standards for investigational drug handling. Key differentiators include its community-focused model, which bridges academic research and local patient access, and its capacity to manage complex multimodal treatment regimens in a non-tertiary care environment. Technical expertise encompasses electronic health record integration for trial enrollment, adverse event reporting per FDA and NCI standards, and patient navigation systems designed to improve retention in oncology trials. No award history is available to infer specific agency relationships or contract performance patterns. Consequently, there is no verifiable data to identify federal agencies with which the organization has formally contracted or the nature of any federal work performed. The organization’s primary NAICS code, 813212, classifies it as a “Medical, Scientific, and Technical Organizations,” indicating its role as a nonprofit entity engaged in clinical research and health service delivery rather than commercial contracting. Its market positioning is rooted in nonprofit oncology care and research participation, not federal procurement. COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM is structured as a nonprofit entity under the 8H classification, indicating it is a private nonprofit organization. It holds no government certifications such as 8(a), HUBZone, or SDVOSB. The organization is geographically anchored in Columbus, Ohio, serving local populations through community oncology networks and academic partnerships, with no indication of federal market engagement based on available data.